A citation-based method for searching scientific literature

Mercè Pineda, Javier Arpa, Raquel Montero, Asunción Aracil, Francisco Domínguez, Marta Galván, Anna Mas, Loreto Martorell, Cristina Sierra, Nuria Brandi, Elena García-Arumí, Miquel Rissech, Daniel Velasco, Juan A Costa, Rafael Artuch. Eur J Paediatr Neurol 2008
Times Cited: 73







List of co-cited articles
611 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial.
Nicholas A Di Prospero, Angela Baker, Neal Jeffries, Kenneth H Fischbeck. Lancet Neurol 2007
189
72

Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.
V Campuzano, L Montermini, M D Moltò, L Pianese, M Cossée, F Cavalcanti, E Monros, F Rodius, F Duclos, A Monticelli,[...]. Science 1996
57

Idebenone treatment in Friedreich patients: one-year-long randomized placebo-controlled trial.
C Mariotti, A Solari, D Torta, L Marano, C Fiorentini, S Di Donato. Neurology 2003
147
56

Friedreich's ataxia: idebenone treatment in early stage patients.
R Artuch, A Aracil, A Mas, C Colomé, M Rissech, E Monrós, M Pineda. Neuropediatrics 2002
83
52

Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia.
A O Hausse, Y Aggoun, D Bonnet, D Sidi, A Munnich, A Rötig, P Rustin. Heart 2002
176
50

Idebenone treatment in Friedreich's ataxia: neurological, cardiac, and biochemical monitoring.
G Buyse, L Mertens, G Di Salvo, I Matthijs, F Weidemann, B Eyskens, W Goossens, N Goemans, G R Sutherland, J L K Van Hove. Neurology 2003
115
45

A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia.
David R Lynch, Susan L Perlman, Thomas Meier. Arch Neurol 2010
122
45

Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study.
P Rustin, J C von Kleist-Retzow, K Chantrel-Groussard, D Sidi, A Munnich, A Rötig. Lancet 1999
273
41

Clinical and genetic abnormalities in patients with Friedreich's ataxia.
A Dürr, M Cossee, Y Agid, V Campuzano, C Mignard, C Penet, J L Mandel, A Brice, M Koenig. N Engl J Med 1996
711
39

Coenzyme Q10 and vitamin E deficiency in Friedreich's ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy.
J M Cooper, L V P Korlipara, P E Hart, J L Bradley, A H V Schapira. Eur J Neurol 2008
103
38


Neurological, cardiological, and oculomotor progression in 104 patients with Friedreich ataxia during long-term follow-up.
Pascale Ribaï, Françoise Pousset, Marie-Laure Tanguy, Sophie Rivaud-Pechoux, Isabelle Le Ber, Franchesca Gasparini, Perrine Charles, Anne-Sophie Béraud, Michele Schmitt, Michel Koenig,[...]. Arch Neurol 2007
75
35

Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up.
Paul E Hart, Raffaele Lodi, Bheeshma Rajagopalan, Jane L Bradley, Jenifer G Crilley, Christopher Turner, Andrew M Blamire, David Manners, Peter Styles, Anthony H V Schapira,[...]. Arch Neurol 2005
143
34

International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology.
P Trouillas, T Takayanagi, M Hallett, R D Currier, S H Subramony, K Wessel, A Bryer, H C Diener, S Massaquoi, C M Gomez,[...]. J Neurol Sci 1997
890
32

Idebenone in Friedreich ataxia cardiomyopathy-results from a 6-month phase III study (IONIA).
Sarah J Lagedrost, Martin St John Sutton, Meryl S Cohen, Gary M Satou, Beth D Kaufman, Susan L Perlman, Christian Rummey, Thomas Meier, David R Lynch. Am Heart J 2011
80
31

Selective iron chelation in Friedreich ataxia: biologic and clinical implications.
Nathalie Boddaert, Kim Hanh Le Quan Sang, Agnès Rötig, Anne Leroy-Willig, Serge Gallet, Francis Brunelle, Daniel Sidi, Jean-Christophe Thalabard, Arnold Munnich, Z Ioav Cabantchik. Blood 2007
287
30

Friedreich's ataxia: clinical pilot trial with recombinant human erythropoietin.
Sylvia Boesch, Brigitte Sturm, Sascha Hering, Hans Goldenberg, Werner Poewe, Barbara Scheiber-Mojdehkar. Ann Neurol 2007
79
28

Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia.
David Herman, Kai Jenssen, Ryan Burnett, Elisabetta Soragni, Susan L Perlman, Joel M Gottesfeld. Nat Chem Biol 2006
305
27

Oxidative stress in patients with Friedreich ataxia.
J B Schulz, T Dehmer, L Schöls, H Mende, C Hardt, M Vorgerd, K Bürk, W Matson, J Dichgans, M F Beal,[...]. Neurology 2000
244
26

Heart hypertrophy and function are improved by idebenone in Friedreich's ataxia.
Pierre Rustin, Agnès Rötig, Arnold Munnich, Daniel Sidi. Free Radic Res 2002
62
30

Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia.
Daniel Velasco-Sánchez, Asuncion Aracil, Raquel Montero, Ana Mas, Lorenzo Jiménez, Mar O'Callaghan, Maria Tondo, Antoni Capdevila, Josep Blanch, Rafael Artuch,[...]. Cerebellum 2011
106
26


HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model.
Myriam Rai, Elisabetta Soragni, Kai Jenssen, Ryan Burnett, David Herman, Giovanni Coppola, Daniel H Geschwind, Joel M Gottesfeld, Massimo Pandolfo. PLoS One 2008
158
21

Safety, tolerability, and pharmacokinetics of high-dose idebenone in patients with Friedreich ataxia.
Nicholas A Di Prospero, Charlotte J Sumner, Scott R Penzak, Bernard Ravina, Kenneth H Fischbeck, J Paul Taylor. Arch Neurol 2007
57
28

Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia.
R Lodi, P E Hart, B Rajagopalan, D J Taylor, J G Crilley, J L Bradley, A M Blamire, D Manners, P Styles, A H Schapira,[...]. Ann Neurol 2001
147
21

Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes.
V Campuzano, L Montermini, Y Lutz, L Cova, C Hindelang, S Jiralerspong, Y Trottier, S J Kish, B Faucheux, P Trouillas,[...]. Hum Mol Genet 1997
545
20

Idebenone in patients with Friedreich ataxia.
L Schöls, M Vorgerd, M Schillings, G Skipka, J Zange. Neurosci Lett 2001
60
25

Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia.
A Rötig, P de Lonlay, D Chretien, F Foury, M Koenig, D Sidi, A Munnich, P Rustin. Nat Genet 1997
760
20

Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale.
S H Subramony, W May, D Lynch, C Gomez, K Fischbeck, M Hallett, P Taylor, R Wilson, T Ashizawa. Neurology 2005
202
19

Diagnosis and treatment of Friedreich ataxia: a European perspective.
Jörg B Schulz, Sylvia Boesch, Katrin Bürk, Alexandra Dürr, Paola Giunti, Caterina Mariotti, Francoise Pousset, Ludger Schöls, Pierre Vankan, Massimo Pandolfo. Nat Rev Neurol 2009
157
19

Neurological effects of recombinant human erythropoietin in Friedreich's ataxia: a clinical pilot trial.
Sylvia Boesch, Brigitte Sturm, Sascha Hering, Barbara Scheiber-Mojdehkar, Hannes Steinkellner, Hans Goldenberg, Werner Poewe. Mov Disord 2008
55
25

How is disease progress in Friedreich's ataxia best measured? A study of four rating scales.
M C Fahey, L Corben, V Collins, A J Churchyard, M B Delatycki. J Neurol Neurosurg Psychiatry 2007
60
21

L-carnitine and creatine in Friedreich's ataxia. A randomized, placebo-controlled crossover trial.
L Schöls, J Zange, M Abele, M Schillings, G Skipka, S Kuntz-Hehner, M C P van Beekvelt, W N J M Colier, K Müller, T Klockgether,[...]. J Neural Transm (Vienna) 2005
37
35

Mortality in Friedreich ataxia.
Amy Y Tsou, Erin K Paulsen, Sarah J Lagedrost, Susan L Perlman, Katherine D Mathews, George R Wilmot, Bernard Ravina, Arnulf H Koeppen, David R Lynch. J Neurol Sci 2011
147
17

Erythropoietin in Friedreich ataxia: no effect on frataxin in a randomized controlled trial.
Caterina Mariotti, Roberto Fancellu, Serena Caldarazzo, Lorenzo Nanetti, Daniela Di Bella, Massimo Plumari, Giuseppe Lauria, Maria D Cappellini, Lorena Duca, Alessandra Solari,[...]. Mov Disord 2012
37
35

Recombinant human erythropoietin: effects on frataxin expression in vitro.
B Sturm, D Stupphann, C Kaun, S Boesch, M Schranzhofer, J Wojta, H Goldenberg, B Scheiber-Mojdehkar. Eur J Clin Invest 2005
75
16

Scale for the assessment and rating of ataxia: development of a new clinical scale.
T Schmitz-Hübsch, S Tezenas du Montcel, L Baliko, J Berciano, S Boesch, C Depondt, P Giunti, C Globas, J Infante, J-S Kang,[...]. Neurology 2006
941
16

Measuring Friedreich ataxia: complementary features of examination and performance measures.
D R Lynch, J M Farmer, A Y Tsou, S Perlman, S H Subramony, C M Gomez, T Ashizawa, G R Wilmot, R B Wilson, L J Balcer. Neurology 2006
119
16

Friedreich's ataxia: point mutations and clinical presentation of compound heterozygotes.
M Cossée, A Dürr, M Schmitt, N Dahl, P Trouillas, P Allinson, M Kostrzewa, A Nivelon-Chevallier, K H Gustavson, A Kohlschütter,[...]. Ann Neurol 1999
250
15

Idebenone: an emerging therapy for Friedreich ataxia.
Thomas Meier, Gunnar Buyse. J Neurol 2009
54
20

Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia.
R Lodi, J M Cooper, J L Bradley, D Manners, P Styles, D J Taylor, A H Schapira. Proc Natl Acad Sci U S A 1999
259
13

Friedreich ataxia: an overview.
M B Delatycki, R Williamson, S M Forrest. J Med Genet 2000
195
13

A0001 in Friedreich ataxia: biochemical characterization and effects in a clinical trial.
David R Lynch, Steven M Willi, Robert B Wilson, M Grazia Cotticelli, Karlla W Brigatti, Eric C Deutsch, Olena Kucheruk, William Shrader, Patrice Rioux, Guy Miller,[...]. Mov Disord 2012
49
20

Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin.
M Babcock, D de Silva, R Oaks, S Davis-Kaplan, S Jiralerspong, L Montermini, M Pandolfo, J Kaplan. Science 1997
708
12

Evolution of the Friedreich's ataxia trinucleotide repeat expansion: founder effect and premutations.
M Cossée, M Schmitt, V Campuzano, L Reutenauer, C Moutou, J L Mandel, M Koenig. Proc Natl Acad Sci U S A 1997
233
12

Genotype and phenotype analysis of Friedreich's ataxia compound heterozygous patients.
M De Castro, J García-Planells, E Monrós, J Cañizares, R Vázquez-Manrique, J J Vílchez, M Urtasun, M Lucas, G Navarro, G Izquierdo,[...]. Hum Genet 2000
43
20

Deferiprone for the treatment of Friedreich's ataxia.
Massimo Pandolfo, Laura Hausmann. J Neurochem 2013
47
19

Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study.
Vincenzo Libri, Cihangir Yandim, Stavros Athanasopoulos, Naomi Loyse, Theona Natisvili, Pui Pik Law, Ping Kei Chan, Tariq Mohammad, Marta Mauri, Kin Tung Tam,[...]. Lancet 2014
77
12

An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels.
Eppie M Yiu, Geneieve Tai, Roger E Peverill, Katherine J Lee, Kevin D Croft, Trevor A Mori, Barbara Scheiber-Mojdehkar, Brigitte Sturm, Monika Praschberger, Adam P Vogel,[...]. J Neurol 2015
48
18

Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin.
H Koutnikova, V Campuzano, F Foury, P Dollé, O Cazzalini, M Koenig. Nat Genet 1997
373
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.